Products Affected - Description

• • Ketorolac injection, Baxter, 15 mg/mL, 1 mL vial, 10 count, NDC 43066-0049-10
  • Ketorolac injection, Baxter, 30 mg/mL, 1 mL vial, 10 count, NDC 43066-0051-10
  • Ketorolac injection, Baxter, 30 mg/mL, 2 mL for intramuscular use vial, 10 count, NDC 43066-0053-10
  • Ketorolac injection, Camber, 15 mg/mL, 1 mL vial, 25 count, NDC 31722-0305-25
  • Ketorolac injection, Camber, 30 mg/mL, 1 mL vial, 25 count, NDC 31722-0306-25
  • Ketorolac injection, Camber, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 31722-0307-25 - discontinued
  • Ketorolac injection, Caplin Steriles USA, 15 mg/mL, 1 mL vial, 25 count, NDC 65145-0146-25
  • Ketorolac injection, Caplin Steriles USA, 30 mg/mL, 1 mL vial, 25 count, NDC 65145-0145-25
  • Ketorolac injection, Caplin Steriles USA, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 65145-0147-25
  • Ketorolac injection, Fresenius Kabi, 30 mg/mL, 1 mL RFID Smart Label prefilled syringe, 24 count, NDC 76045-0209-10
  • Ketorolac injection, Fresenius Kabi, 30 mg/mL, 1 mL vial, 25 count, NDC 63323-0162-01
  • Ketorolac injection, Fresenius Kabi, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 63323-0162-02
  • Ketorolac injection, Glenmark, 15 mg/mL, 1 mL vial, 25 count, NDC 68462-0755-25
  • Ketorolac injection, Glenmark, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 68462-0757-25
  • Ketorolac injection, Pfizer, 15 mg/mL, 1 mL vial, 25 count, NDC 00409-3793-25
  • Ketorolac injection, Pfizer, 30 mg/mL, 1 mL vial, 25 count, NDC 00409-3795-25
  • Ketorolac injection, Pfizer, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 00409-3796-25
  • Ketorolac injection, Sola, 15 mg/mL, 1 mL vial, 25 count, NDC 70512-0842-25
  • Ketorolac injection, Sola, 30 mg/mL, 1 mL vial, 25 count, NDC 70512-0843-25
  • Ketorolac injection, Sola, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 70512-0844-25

Reason for the Shortage

• • Alembic has ketorolac injection available.
  • Baxter has ketorolac injection on shortage due to a third-party supplier issue.
  • Camber has ketorolac injection available. Ketorolac 60 mg/2mL intramuscular injection is discontinued.
  • Caplin Steriles has ketorolac injection available.
  • Fosun Pharma has ketorolac injection available.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Glenmark did not provide a reason for the shortage.
  • Pfizer is relaunching with new NDC, these presentations do not have an estimated release date.
  • Sagent did not provide a reason for the shortage.
  • Sola has temporarily discontinued ketorolac injection.

Available Products

• • Ketorolac injection, Fosun Pharma, 30 mg/mL, 1 mL vial, 25 count, NDC 72266-0118-25
  • Ketorolac injection, Fosun Pharma, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 72266-0119-25
  • Ketorolac injection, Fresenius Kabi, 15 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0107-10
  • Ketorolac injection, Fresenius Kabi, 15 mg/mL, 1 mL vial, 25 count, NDC 63323-0161-01
  • Ketorolac injection, Fresenius Kabi, 30 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0104-10
  • Ketorolac injection, Fresenius Kabi, 30 mg/mL, 2 mL for intramuscular use prefilled syringe, 24 count, NDC 76045-0105-20
  • Ketorolac injection, Sagent, 15 mg/mL, 1 mL vial, 25 count, NDC 25021-0700-01
  • Ketorolac injection, Sagent, 30 mg/mL, 1 mL vial, 25 count, NDC 25021-0701-01
  • Ketorolac injection, Sagent, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 25021-0701-02

• • Baxter has ketorolac 30 mg/mL 1 mL vials in limited supply. The 15 mg/mL 1 mL vials are on back order and the company cannot estimate a release date. The 60 mg/2 mL vials for intramuscular injection are on back order and the company cannot estimate a release date.
  • Fresenius Kabi has ketorolac 30 mg/mL 1 mL RFID prefilled syringes on back order and the company estimates a release date of mid-October 2026. The 30 mg/mL 1 mL vials are on back order and the company estimates a release date of mid-August 2026. The 60 mg/2mL vials for intramuscular injection are on back order and the company estimates a release date of mid- to late-August 2026.
  • Glenmark has ketorolac 15 mg/mL 1 mL vials and 30 mg/mL 1 mL vials on back order and the company cannot estimate a release date. The 60 mg/2 mL vials for intramuscular injection are on back order and the company cannot estimate a release date.
  • Pfizer has ketorolac 15 mg/mL 1 mL vials and 30 mg/mL 1 mL vials on back order and the company cannot estimate a release date. The 60 mg/2 mL vials for intramuscular injection are on back order and the company cannot estimate a release date.